Clinical trials

  • DULOXETINE for Functional somatic disorder
  • ENTINOSTAT for High-risk relapsed or refractory malignant disease|Medulloblastoma|Ependymoma|Atypical teratoid/rhabdoid tumor (ATRT)|Embryonal tumour with multilayered rosettes (ETMR)|Pediatric high-grade glioma (including DIPG)|Neuroblastoma|Wilms tumour (nephroblastoma)|Rhabdoid tumour|Rhabdomyosarcoma|Pediatric embryonal small round blue cell tumours|Other pediatric solid tumours
  • PEMBROLIZUMAB for Kaposi's sarcoma
  • AZD7798 for Crohn's disease|Active ileal Crohn's disease with ileostomy
  • HUMAN IGG1 LAMBDA FAB FRAGMENT AGAINST THYMIC STROMAL LYMPHOPOIETIN for Asthma
  • INTERFERON ALFA; DEOXYRIBONUCLEIC ACID; INTERFERON GAMMA; INTERLEUKIN-1; INTERLEUKIN-2; RIBONUCLEIC ACID; SPECIFIC NUCLEIC ACID SNA-XFSA; SPECIFIC NUCLEIC ACID SNA-XFSB; SPECIFIC NUCLEIC ACID SNA-XFSC; RIBONUCLEIC ACID K10; RIBONUCLEIC ACID K30; TUMOR NECROSIS FACTOR-ALPHA for Epstein-Barr virus infection
  • LEFLUNOMIDE for Polymyalgia rheumatica
  • Venetoclax for Acute myeloid leukemia
  • cebsulfase alfa for Metachromatic leukodystrophy | Late infantile metachromatic leukodystrophy
  • DERMATOPHAGOIDES FARINAE for Allergies
  • NAVEPEGRITIDE for Achondroplasia
  • TORIPALIMAB for Advanced hepatocellular carcinoma | Hepatocellular carcinoma